CHI3L1 and chronic obstructive pulmonary disease: Serum CHI3L1 is upregulated in patients with chronic inflammatory diseases like asthma and chronic obstructive pulmonary disease (COPD) [168], and it is a biomarker of poor survival in various cancers (as reviewed in [169]).